The Bone Health project is a collaboration between the University of Oxford, PRIMIS and the Oxford AHSN. It is a primary-care based medicines optimisation project that aims to improve the management of patients at high risk of fragility fracture through a focus on appropriate medication initiation.
This page is for clinicians participating in the project. See below for links to resources which may be beneficial when undertaking the project, including links to clinical guidelines, published papers and patient information.
Clinician resources
-
Fracture risk assessment
- FRAX: https://www.sheffield.ac.uk/FRAX/
- QFracture: https://qfracture.org/index.php
-
Clinical guidelines
- National Osteoporosis Guideline Group (NOGG 2021): National Osteoporosis Guidelines Group UK (nogg.org.uk)
- NICE CG146 Osteoporosis: assessing the risk of fragility fracture: Overview | Osteoporosis: assessing the risk of fragility fracture | Guidance | NICE
- SIGN142: management of osteoporosis and the prevention of fragility fractures: https://www.sign.ac.uk/our-guidelines/management-of-osteoporosis-and-the-prevention-of-fragility-fractures/
-
Bulletins/updates
- PrescQIPP Bulletin 231: bisphosphonate treatment for osteoporosis: https://www.prescqipp.info/our-resources/bulletins/bulletin-231-bisphosphonate-treatment-for-osteoporosis/
- Drug Safety Update – Bisphosphonates: atypical femoral fractures: https://www.gov.uk/drug-safety-update/bisphosphonates-atypical-femoral-fractures
-
QOF indicators
- Osteoporosis – prevention of fragility fractures: https://cks.nice.org.uk/topics/osteoporosis-prevention-of-fragility-fractures/goals-outcome-measures/qof-indicators/
Further reading
-
- Royal Osteoporosis Society tools and resources for healthcare professionals: https://theros.org.uk/healthcare-professionals/tools-and-resources/
- Bordes et al 2020. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies: https://doi.org/10.1371/journal.pone.0227765
- Hiligsmann et al 2019. Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organised by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF): https://doi.org/10.1007/s00198-019-05104-5
- Imaz et al 2010. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis: https://link.springer.com/article/10.1007/s00198-009-1134-4
- Fink et al 2019. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: https://doi.org/10.7326/M19-0533
- Warriner et al 2009. Adherence to osteoporosis treatments – room for improvement: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913429/
Patient resources
-
Royal Osteoporosis Society
- Information for newly diagnosed: https://theros.org.uk/information-and-support/osteoporosis/newly-diagnosed/
- Information and support: https://theros.org.uk/information-and-support/
- Free helpline: 0808 800 0035
-
Royal College of Physicians
- Hip fracture guide for family carers: https://www.rcplondon.ac.uk/projects/hip-fracture-guide-family-carers
- Strong bones after 50 – staying on treatment: https://www.rcplondon.ac.uk/projects/outputs/strong-bones-after-50-staying-treatment
-
The Association of UK Dietitians
- Osteoporosis and diet – food fact sheet: https://www.bda.uk.com/resource/osteoporosis-diet.html
-
Patient information
- Osteoporosis leaflet: https://patient.info/bones-joints-muscles/osteoporosis-leaflet
-
National Institute for Health and Care Excellence (NICE)
- Bisphosphonate for treating osteoporosis – Patient Decision Aid: Bisphosphonates for treating osteoporosis patient decision aid (nice.org.uk)